BIOPHARMA HOLDING ApS: Financial statements 2017
CVR: 35206086
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
BIOPHARMA HOLDING ApS (CVR 35206086) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 298,043 and a net result of DKK -8,154,301 compared with DKK -6,851,695 the year before. That is a decrease of 21.4% compared with the year before. Equity in the 2017 report amounted to DKK 119,027,657. The solvency ratio was 99.4%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 298,043
- Profit/Loss
- DKK -8,154,301
- Equity
- DKK 119,027,657
- Total Assets
- DKK 119,706,848
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 298 t. | -8.2 mio. | 119 mio. | 1 |
| 2016 | - | 379 t. | -6.9 mio. | 127.2 mio. | 2 |
| 2015 | - | 149 t. | -200.3 mio. | 134 mio. | - |
| 2014 | - | 183 t. | 10.6 mio. | 334.4 mio. | - |
Official annual report
Keep an eye on BIOPHARMA HOLDING ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
BIOPHARMA HOLDING ApS has published its annual report for 2016. Gross profit came to DKK 379,130, and the net result was DKK -6,851,695.
About BIOPHARMA HOLDING ApS
BIOPHARMA HOLDING ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2013. The company has been dissolved on 17 July 2026. The company was registered under the industry Finansielle holdingselskaber. The company has 1 employee (2017). In 2024, the company reported a gross profit of DKK 921,360 and a net result of DKK -3,732,682 compared with DKK -20,576,349 the year before. Equity in the 2024 report amounted to DKK 2,921,095.